Literature DB >> 24880970

[Infections and use of antibiotics in residents of long-term care facilities in Hungary].

Rita Szabó1, Karolina Böröcz1.   

Abstract

INTRODUCTION: Healthcare associated infections and antimicrobial use are common among residents of long-term care facilities. Faced to the lack of standardized data, the European Centre for Disease Prevention and Control funded a project with the aim of estimating prevalence of infections and antibiotic use in European long-term care facilities. AIM: The aim of the authors was to present the results of the European survey which were obtained in Hungary.
METHOD: In Hungary, 91 long-term care facilities with 11,823 residents participated in the point-prevalence survey in May, 2013.
RESULTS: The prevalence of infections was 2.1%. Skin and soft tissues infections were the most frequent (36%), followed by infections of the respiratory (30%) and urinary tract (21%). Antimicrobials were mostly prescribed for urinary tract infections (40.3%), respiratory tract infections (38.4%) and skin and soft tissue infections (13.2%). The most common antimicrobials (97.5%) belonged to the ATC J01 class of "antibacterials for systemic use".
CONCLUSIONS: The results emphasise the need for a national guideline and education for good practice in long-term care facilities.

Entities:  

Keywords:  antibiotikumhasználat; antimicrobial use; bentlakásos szociális intézmény; fertőzés; healthcare-associated infections; long-term care facility; point-prevalence survey; pontprevalencia-vizsgálat

Mesh:

Substances:

Year:  2014        PMID: 24880970     DOI: 10.1556/OH.2014.29876

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Use of hand hygiene agents as a surrogate marker of compliance in Hungarian long-term care facilities: first nationwide survey.

Authors:  Rita Szabó; Júlia Morvai; Fernando Bellissimo-Rodrigues; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2015-07-31       Impact factor: 4.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.